Pailin Biology (000403.SZ) released its first half-year performance report, with a net profit of 2.36 billion yuan attributable to the parent company, a decrease of 27.89%.

date
21/08/2025
Intelligent Wealth News, Palind Bio (000403.SZ) released its 2025 semi-annual report. The company's operating income was 986 million yuan, a decrease of 13.18% year-on-year. Net profit attributable to shareholders of the listed company was 236 million yuan, a decrease of 27.89% year-on-year. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 215 million yuan, a decrease of 27.63% year-on-year. The basic earnings per share was 0.25 yuan.